ArticleAnnals of medicine and surgery (2012)2026
Efficacy and safety of SGLT2 inhibitor empagliflozin in T2DM with established cardiovascular disease: a systematic review and meta-analysis of RCTs.
Omar Abunada et al.PubMed ↗Full text ↗Publisher ↗
No numbers read from the abstract.